Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

Aims The aim of this study was to evaluate the low-density lipoprotein cholesterol lowering efficacy and safety of a bempedoic acid 180 mg and ezetimibe 10 mg fixed-dose combination in patients with hypercholesterolemia and a high risk of cardiovascular disease receiving maximally tolerated statin t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of preventive cardiology 2020-04, Vol.27 (6), p.593-603, Article 2047487319864671
Hauptverfasser:	Ballantyne, Christie M, Laufs, Ulrich, Ray, Kausik K, Leiter, Lawrence A, Bays, Harold E, Goldberg, Anne C, Stroes, Erik SG, MacDougall, Diane, Zhao, Xin, Catapano, Alberico L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticholesteremic Agents - administration & dosage Anticholesteremic Agents - adverse effects Biomarkers - blood Cardiac & Cardiovascular Systems Cardiovascular Diseases - blood Cardiovascular Diseases - diagnosis Cardiovascular Diseases - prevention & control Cardiovascular System & Cardiology Cholesterol, LDL - blood Dicarboxylic Acids - administration & dosage Dicarboxylic Acids - adverse effects Double-Blind Method Down-Regulation Drug Combinations Drug Treatment Ezetimibe - administration & dosage Ezetimibe - adverse effects Fatty Acids - administration & dosage Fatty Acids - adverse effects Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypercholesterolemia - blood Hypercholesterolemia - diagnosis Hypercholesterolemia - drug therapy Life Sciences & Biomedicine Male Middle Aged Science & Technology Time Factors Treatment Outcome United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!